These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34027650)

  • 41. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
    Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B
    Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.
    Dzobo K; Chiririwa H; Dandara C; Dzobo W
    OMICS; 2021 Jan; 25(1):13-22. PubMed ID: 32857671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19
    Vignesh R; Swathirajan CR; Tun ZH; Rameshkumar MR; Solomon SS; Balakrishnan P
    Front Immunol; 2020; 11():607734. PubMed ID: 33569053
    [No Abstract]   [Full Text] [Related]  

  • 44. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
    Roshanravan N; Seif F; Ostadrahimi A; Pouraghaei M; Ghaffari S
    Arch Med Res; 2020 Oct; 51(7):608-612. PubMed ID: 32682575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis.
    Danladi J; Sabir H
    J Neuroimmunol; 2021 Sep; 358():577632. PubMed ID: 34186336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease.
    Pasrija R; Naime M
    Int Immunopharmacol; 2021 Jan; 90():107225. PubMed ID: 33302033
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunomodulatory agents as potential therapeutic or preventive strategies for COVID-19.
    Gaziano R; Pistoia ES; Campione E; Fontana C; Marino D; Favaro M; Pica F; Di Francesco P
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4174-4184. PubMed ID: 34156699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
    Front Immunol; 2021; 12():749291. PubMed ID: 34867978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A clinical trial of IL-15 and IL-21 combination therapy for COVID-19 is warranted.
    Wilz SW
    Cytokine Growth Factor Rev; 2021 Apr; 58():49-50. PubMed ID: 33199178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus.
    Darbeheshti F; Mahdiannasser M; Uhal BD; Ogino S; Gupta S; Rezaei N
    Rev Med Virol; 2021 Nov; 31(6):e2234. PubMed ID: 33724604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications.
    Hirawat R; Saifi MA; Godugu C
    Life Sci; 2021 Feb; 267():118923. PubMed ID: 33358906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RS-5645 attenuates inflammatory cytokine storm induced by SARS-CoV-2 spike protein and LPS by modulating pulmonary microbiota.
    Liu T; Wu J; Han C; Gong Z; Regina G; Chen J; Dou F; Silvestri R; Chen C; Yu Z
    Int J Biol Sci; 2021; 17(13):3305-3319. PubMed ID: 34512148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quinacrine as a potential treatment for COVID-19 virus infection.
    Pineda B; Pérez de la Cruz V; Hernández Pando R; Sotelo J
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):556-566. PubMed ID: 33506949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options.
    Choudhary S; Sharma K; Silakari O
    Microb Pathog; 2021 Jan; 150():104673. PubMed ID: 33278517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection?
    Haggag YA; El-Ashmawy NE; Okasha KM
    Med Hypotheses; 2020 Nov; 144():109957. PubMed ID: 32531538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lessons learned: new insights on the role of cytokines in COVID-19.
    Buszko M; Nita-Lazar A; Park JH; Schwartzberg PL; Verthelyi D; Young HA; Rosenberg AS
    Nat Immunol; 2021 Apr; 22(4):404-411. PubMed ID: 33723418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
    Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
    Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.
    Root-Bernstein R
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19.
    Talukdar J; Bhadra B; Dattaroy T; Nagle V; Dasgupta S
    Biomed Pharmacother; 2020 Dec; 132():110886. PubMed ID: 33113418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
    Torabi-Rahvar M; Rezaei N
    Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.